» Articles » PMID: 25600557

Hepatitis C Virus Infection and Risk Factors in the General Population: a Large Community-based Study in Eastern China, 2011-2012

Overview
Date 2015 Jan 21
PMID 25600557
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Limited information is available on the prevalence of hepatitis C virus (HCV) in the general population in China. A community-based epidemiological study was conducted in three counties in eastern China. A total of 149 175 individuals were investigated in 60 communities in three counties in Jiangsu province, eastern China, of whom 1175 subjects [0·79%, 95% confidence interval (CI) 0·74-0·83] were HCV antibody positive. The prevalence was low in children (0·09%, 95% CI 0·04-0·17), but increased progressively from adolescents (0·20%, 95% CI 0·15-0·28) to adults aged ⩾21 years (95% CI 0·15-1·64). Women had a higher prevalence of HCV infection than men in most age groups. In a multilevel regression analysis, age, sex, education, occupation, blood transfusion [odds ratio (OR) 2·91, 95% CI 1·09-5·37], invasive testing (OR 1·28, 95% CI 1·14-1·61), and dental therapy (OR 2·27, 95% CI 1·41-3·42) were associated with HCV infection. In conclusion, although the prevalence of HCV in this population was lower than reported from national levels, the total reservoir of infection is significant and warrants public health measures, such as health education to limit the magnitude of the problem.

Citing Articles

Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses.

Gizamba J, Finch B, Wang S, Klausner J BMC Public Health. 2025; 25(1):687.

PMID: 39972312 PMC: 11841175. DOI: 10.1186/s12889-025-21668-w.


Synergistic effects of organic fertilizer and corn straw on microorganisms of pepper continuous cropping soil in China.

Gao J, Pei H, Xie H Bioengineered. 2020; 11(1):1258-1268.

PMID: 33124497 PMC: 8291890. DOI: 10.1080/21655979.2020.1840753.


Prevalence of Anti-HCV Antibody Among the General Population in Mainland China Between 1991 and 2015: A Systematic Review and Meta-analysis.

Gao Y, Yang J, Sun F, Zhan S, Fang Z, Liu X Open Forum Infect Dis. 2019; 6(3):ofz040.

PMID: 30863789 PMC: 6408870. DOI: 10.1093/ofid/ofz040.


Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.

Xiong J, Huang J, Sun W, Wang J, Chen D Clinics (Sao Paulo). 2015; 70(8):563-8.

PMID: 26247669 PMC: 4518765. DOI: 10.6061/clinics/2015(08)06.

References
1.
Charlebois A, Lee L, Cooper E, Mason K, Powis J . Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients. J Viral Hepat. 2012; 19(12):836-42. DOI: 10.1111/j.1365-2893.2012.01648.x. View

2.
Nelson P, Mathers B, Cowie B, Hagan H, Des Jarlais D, Horyniak D . Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791):571-83. PMC: 3285467. DOI: 10.1016/S0140-6736(11)61097-0. View

3.
Zhou Y, Liu F, Yao Z, Duo L, Li H, Sun Y . Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. PLoS One. 2011; 6(1):e16349. PMC: 3025010. DOI: 10.1371/journal.pone.0016349. View

4.
Rao H, Sun D, Yang R, Liu F, Wang J, Feng B . Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12-19-year cohort study. J Gastroenterol Hepatol. 2011; 27(3):526-32. DOI: 10.1111/j.1440-1746.2011.06880.x. View

5.
Ruan Y, Liang S, Zhu J, Li X, Pan S, Liu Q . Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China. Sex Transm Dis. 2013; 40(4):323-8. DOI: 10.1097/OLQ.0b013e31827fd4d4. View